Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Clinical trial NCT03397394 · TERMINATED

Trial details

NCT number: NCT03397394
Sponsor: pharmaand GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Urothelial Carcinoma Metastatic Urothelial Carcinoma Renal Pelvis Carcinoma Ureter Carcinoma Urinary Bladder Carcinoma Urethra Carcinoma Muscle Invasive Bladder Cancer

Start date: 2018-06-01
Primary completion: 2019-12-12
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.